Hinge Health holder plans $13.7M stock sale

Hinge Health, Inc. (HNGE) reports that stockholder Suthasini Mogun has filed a notice of proposed sale under Rule 144 for up to 150,000 shares of common stock.

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) reports that stockholder Suthasini Mogun has filed a notice of proposed sale under Rule 144 for up to 150,000 shares of common stock. The shares, with an aggregate market value of $13,696,500, may be sold through Morgan Stanley Smith Barney LLC on the NYSE. The notice lists 62,468,721 shares of common stock as the relevant share count. The securities were acquired from restricted stock units vesting on May 21, 2025 and previously exercised stock options originally exercised on May 20, 2021.

Key Figures

Shares proposed for sale: 150,000 shares Aggregate market value of proposed sale: $13,696,500 Referenced share count: 62,468,721 shares +3 more

6 metrics

Shares proposed for sale 150,000 shares Maximum number of Hinge Health, Inc. common shares covered by the Rule 144 notice

Aggregate market value of proposed sale $13,696,500 Total market value of the 150,000 HNGE shares referenced in the notice

Referenced share count 62,468,721 shares Share count of Hinge Health, Inc. common stock referenced in the Rule 144 section

Restricted Stock Units shares 3,321 shares Portion of securities to be sold acquired from RSUs dated May 21, 2025

Previously exercised option shares 146,679 shares Portion of securities to be sold from options originally exercised on May 20, 2021

Notice date September 10, 2026 Date of the Rule 144 notice signed by Suthasini Mogun

Key Terms

Rule 144, Restricted Stock Units, Previously Exercised Stock Options, aggregate market value

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 05/21/2025 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Previously Exercised Stock Options financial

"Common | 05/20/2021 | Previously Exercised Stock Options | Issuer"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 150000 | 13696500.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing for HNGE disclose?

It discloses that stockholder Suthasini Mogun has filed a notice under Rule 144 to sell up to 150,000 shares of Hinge Health, Inc. common stock, with an aggregate market value of $13,696,500, through Morgan Stanley Smith Barney LLC on the NYSE.

How many Hinge Health (HNGE) shares are proposed to be sold and at what value?

The notice covers a proposed sale of up to 150,000 shares of Hinge Health, Inc. common stock, with an aggregate market value stated as $13,696,500 in the filing.

What share count for Hinge Health, Inc. (HNGE) is referenced in the Form 144?

The Form 144 references 62,468,721 shares of Hinge Health, Inc. common stock as the relevant share count in connection with the proposed Rule 144 sale.

How and where may the HNGE shares be sold under this Form 144?

The filing states that the 150,000 shares of Hinge Health, Inc. common stock may be sold through Morgan Stanley Smith Barney LLC on the NYSE.

How were the Hinge Health (HNGE) shares in this Form 144 acquired?

The filing explains that the shares were acquired upon vesting of restricted stock units dated May 21, 2025 and from previously exercised stock options originally exercised on May 20, 2021, with vesting activity between May 20, 2021 and March 22, 2023.

When was the Form 144 notice for Hinge Health, Inc. filed?

The notice is dated September 10, 2026, and it covers a proposed Rule 144 sale of Hinge Health, Inc. common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:44 PM Accepted by SEC EDGAR 09/10/2026 - 04:44 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002063236
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 Market Street, Suite 700 San Francisco CALIFORNIA 94105
Phone	4157262206
Name of Person for Whose Account the Securities are To Be Sold	SUTHASINI MOGUN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	150000	13696500.00	62468721	09/10/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted Stock Units	Issuer			3321	05/21/2025	N/A
Common	05/20/2021	Previously Exercised Stock Options	Issuer			146679	05/20/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of previously exercised options during the period of 5/20/2021 through 03/22/2023
Date of Notice	09/10/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Suthasini Mogun
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)